Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body

References

• Endophthalmitis Vitrectomy Study GroupResults of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitisArch Ophthamol19951131214791496
   PubMedGoogle Scholar
• CalleganMCEngelbertMParkeDW2ndJettBDGilmoreMSBacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactionsClin Microbiol Rev200215111112411781270
   PubMed Web of Science ®Google Scholar
• CalleganMCGilmoreMSGregoryMBacterial endophthalmitis: therapeutic challenges and host-pathogen interactionsProg Retin Eye Res200726218920317236804
   PubMed Web of Science ®Google Scholar
• JacksonTLEykynSJGrahamEMStanfordMREndogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported casesSurv Ophthalmol200348440342312850229
   PubMed Web of Science ®Google Scholar
• HanDPWisniewskiSRWilsonLASpectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy StudyAm J Ophthalmol199612211178659579
   PubMed Web of Science ®Google Scholar
• LifshitzTLapid-GortzakRFinkelmanYKlempererIVancomycin and ceftazidime incompatibility upon intravitreal injectionBr J Ophthalmol200284111711810691328
   PubMed Web of Science ®Google Scholar
• FiscellaRGPhysical incompatibility of vancomycin and ceftazidime for intravitreal injectionArch Ophthalmol199311167308512464
   PubMedGoogle Scholar
• FerrerCRodríguezAAbadJLFernandezJAlióJLBactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitisBr J Ophthalmol200892567868218211926
   PubMed Web of Science ®Google Scholar
• ErnstMEErnstEJKlepserMELevofloxacin and trovafloxacin: the next generation of fluoroquinolones?Am J Health Syst Pharm19975422256925849397218
   PubMed Web of Science ®Google Scholar
• SchwabIRFriedlaenderMMcCulleyJLichtensteinSJMoranCTLevofloxacin Bacterial Conjunctivitis Active Control Study GroupA phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitisOphthalmology2003110345746512623805
   PubMed Web of Science ®Google Scholar
• DajcsJJThibodeauxBAMarquartMEGirgisDOTraidejMO’CallaghanRJEffectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitisAntimicrob Agents Chemother20044861948195215155183
   PubMed Web of Science ®Google Scholar
• YildirimOOzOAslanGCinelLDelialiogluNKanikAThe efficacy of intravitreal levofloxacin and intravitreal dexamethasone in experimental Staphylococcus epidermidis endophthalmitisOphthalmic Res200234634935612483022
   PubMed Web of Science ®Google Scholar
• DurandMLBacterial endophthalmitisCurr Infect Dis Rep20091128328819545497
   PubMedGoogle Scholar
• JabsDANewmanCDe BustrosSPolkBFTreatment of cytomegalovirus retinitis with ganciclovirOphthalmology19879478248302821465
   PubMed Web of Science ®Google Scholar
• ColthurstMJWilliamsRLHiscottPSGriersonIBiomaterials used in the posterior segment of the eyeBiomaterials200021764966510711963
   PubMed Web of Science ®Google Scholar
• YasukawaTOguraYTabataYKimuraHWiedemannPHondaYDrug delivery systems for vitreoretinal diseasesProg Retin Eye Res200423325328115177203
   PubMed Web of Science ®Google Scholar
• GaoQMouSGeJA new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valveEye (Lond)200822346146817525767
   PubMed Web of Science ®Google Scholar
• GaoQChenXGeJRefractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyesInvest Ophthalmol Vis Sci20095073529353419264881
   PubMed Web of Science ®Google Scholar
• LiuYJiangZGaoQTechnical standards of a foldable capsular vitreous body in terms of mechanical, optical, and biocompatible propertiesArtif Organs2010341083684520618225
   PubMed Web of Science ®Google Scholar
• LinXGeJGaoQEvaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachmentInvest Ophthalmol Vis Sci201152137438120811065
   PubMed Web of Science ®Google Scholar
• LiuYKeQChenJSustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous bodyInvest Ophthalmol Vis Sci20105131636164219834025
   PubMed Web of Science ®Google Scholar
• HerbertENPearceIAMcGalliardJWongDGroenewaldCVitreous penetration of levofloxacin in the uninflamed phakic human eyeBr J Ophthalmol200286438738911914204
   PubMed Web of Science ®Google Scholar
• GurlerBOzkulYBitirenMKaradedeSGurkanTA study on the toxicity of intravitreal levofloxacin in rabbitsCurr Eye Res200224425326212324863
   PubMed Web of Science ®Google Scholar
• OhkuboSYamashitaYTanahashiTHigashideTTorisakiMSugiyamaKPharmacokinetics of intravitreal injection of levofloxacinInvest Ophthalmol Vis Sci200445 E-abstract 3951.
   Web of Science ®Google Scholar
• HallerJABandelloFBelfortRJrOZURDEX GENEVA Study GroupRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology201011761134114620417567
   PubMed Web of Science ®Google Scholar
• PavesioCZierhutMBairiKComstockTLUsnerDWFluocinolone Acetonide Study GroupEvaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitisOphthalmology2010117356757520079922
   PubMed Web of Science ®Google Scholar
• MounierMPloyMCChauvinMAdenisJPDenisFStudy of intraocular diffusion of ofloxacin in humans and rabbitsPathol Biol (Paris)1992405529533 French.1495839
   PubMedGoogle Scholar
• SugiokaKFukudaMKomotoSItahashiMYamadaMShimomuraYIntraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacinClin Ophthalmol2009355355719898627
   PubMedGoogle Scholar